Study on management of fungal infections of nose and parnasal sinuses

Prasad A. Kelkar, Jyoti V. Hirekerur


Background: From last few years, the fungal infection has been increasing due to greatly enhanced international traffic and as opportunistic infections in consequence of use of powerful cytotoxic drugs. The disease invariably occurs in diabetics, usually with ketoacidosis, immune compromised patients. Hence, we planned to undertake the present study to evaluate a standard method of management of fungal infections of nose and paranasal sinuses.

Methods: A detailed examination of the nose and pranasal sinuses was carried out in the department of ENT. The patients were continuously monitored with pulse oximetry and ECG monitor. In all patients, nasal endoscopy was performed.  

Results: In this study, fungal infections of the nose and paranasal sinuses were found to be common between 20 and 50 years of age. Aspergillosis was the commonest sinonasal fungal infection followed by allergic fungal sinusitis, rhinosporidiosis and mucormycosis.

Conclusions: Early detection, proper and adequate dose of antifungal agents, timely surgical intervention in the form of debridement and sphenoethmoidectomy and orbital exenteration improve the survival rate in the disease of sinonasal fungal infections.



Fungal infection, Paranasal sinus, Aspergillosis, Nose

Full Text:



Esrafi A, Aristides S, Kwanghoi, Patore P. Twenty – five years experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope. 1984;94:1060-2.

Allphin AL, Strauses M, Abdul KF. Allergic fungal sinuritis: Problems in diagnosis and treatment. Laryngoscope. 1991;10:815-9.

Bennett John E. Antimicrobial agents:Antifungal agent, The pharmacological basis of therapeutic Goodman Gilmans. Chapter 57. 12th Edition. The McGraw Hill companies; 2011: 1175-1190.

Chatterjee SS, Chakrabarti A. Epidemiology and medical mycology of fungal rhinosinusitis. Int J Otorhinolaryngol Clin. 2009;1:1-13.

Nicolai P, Lombardi D, Tomenzoli D, Villaret AB, Piccioni M, Mensi M, et al. Fungus ball of the paranasal sinuses: experience in 160 patients treated with endoscopic surgery. Laryngoscope. 2009;119(11):2275-9.

Andrew B, Willam L, Bert MR, Hugh BF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980;90(4):635–48.

Folker Randy J, Marple Bradley F, Mabry Richard L, Mabry CS. Treatment of allergic fungal sinusitis: A comparison trial of postoperative immunotherapy with specific fungal antigens. Laryngoscope. 1998;108:1623-7.

Manning Scott C, Holman Marie. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngscope. 1998;108:1485-96.

Manning SC, Vuitch F, Weinberg AG, Brown OE. Allergic Aspergillosis: A newly recognized form of sinusitis in the pediatric populatin. Laryngoscope. 1989;99:681-5.

Manning SC, Merkel M, Kriesel K, Vuitch F, Marple B. Computed tomography and magnetic resonance diagnosis of allergic fungal sinusitis. Laryngoscope. 1997;107:170-6.

Daghistani KJ, Jamal TS, Zaher S, Nassif OI. Allergic aspergillus sinusitis with proptosis. J Laryngol Otol. 1992;106:799-803.

Pillsbury Harold L, Newton D, Fischer MD. Rhino –cerebral–mucormycosis. Arch Otoaryngol. 1997;103:600-4.

Lewis MJR, Newman RK, LackLand AFB. Aspergillosis of the nose and paranasal sinuses. Laryngoscope. 1982;92:764–6.

Nathan Marshall D, Paul KA, Charles L, Davis C. Entomophthorales infection of the maxillofacial region. Laryngoscope. 1982;92:767-9.

Nair KK. Clinical trial of diaminodipenyl sulfone (DDS) in nasal and nasopharyngeal rhinosporidiosis. Laryngoscope. 1979;89:291-5.

Maniglia AJ, Mintz DH, Novak S, Miami FL. Cephalic phycomycosis: A report of eight cases. Laryngoscope. 1982;92:755-60.

Weber RS, Gabriel LB, Hpuston TX. Treatment of invasive aspergillus sinusitis with liposomal amphotericin B. Laryngoscope. 1987;97:937-41.

Carpenter F. Meunier, Snoeck R, Gerain J, Muller C. Amphotericin B. nasal spray as prophylaxis against aspergillosis in patient with neutropenia. New England J Med. 1984:1056.

Nair KK. Clinical trial of diaminodipenyl sulfone (DDS) in nasal and nasopharyngeal rhinosporidiosis. Laryngoscope. 1979;89:291-5.

Linnea PK, Wang M, Canalis RF, Elliot A. Rhinocerebral mucornycosis: Evolution of the disease and treatment options Laryngoscope. 1997;107:855-62.